Innoviva Inc
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
INVA$19.08+0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
| Page | |
|---|---|
| Consolidated Balance Sheets as of December 31, 2023 and December 31, 2022 | 93 |
| Consolidated Statements of Income for each of the three years in the period ended December 31, 2023 | 94 |
| Consolidated Statements of Comprehensive Income for each of the three years in the period ended December 31, 2023 | 95 |
| Consolidated Statements of Stockholders’ Equity for each of the three years in the period ended December 31, 2023 | 96 |
| Consolidated Statements of Cash Flows for each of the three years in the period ended December 31, 2023 | 97 |
| Notes to Consolidated Financial Statements | 98 |
| Reports of Independent Registered Public Accounting Firm (PCAOB ID 34) | 138 |
| Report of Independent Registered Public Accounting Firm (PCAOB ID 248) | 140 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.